PCSK1N and synucleinopathy: As such, the potential of SAAs to reliably diagnose α-synucleinopathies early in their pathogenesis cannot be understated, especially in light of recent studies indicating the biological quantitative potential of SAAs beyond a yes/no diagnosis [14, 30, 31].